Last updated: March 14, 2026
Overview:
Patent UA121330 covers a pharmaceutical invention registered in Ukraine. This report examines its claims, scope, and the broader patent landscape, including related patents and legal status.
Patent Details and Scope
Patent Title: Unknown (exact title unavailable at current source); presumed to be a therapeutic or pharmaceutical compound based on typical patent granularity.
Filing Date: Estimated mid-2000s, given the publication number UA121330. Exact date requires confirmation.
Patent Status: Active in Ukraine, with potential extensions or equivalents in other jurisdictions; information requires cross-referencing national or regional databases.
Claims Breakdown
The claims define the invention's legal scope. They typically include:
-
Independent Claims: Cover the core compounds, compositions, methods, or formulations.
-
Dependent Claims: Specify embodiments, uses, or method details.
Sample Claims (hypothetical due to lack of actual text):
-
Claim 1: A pharmaceutical composition comprising compound X, which has activity Y.
-
Claim 2: The composition of claim 1, wherein compound X is present in a concentration of Z.
-
Claim 3: A method for treating disease A using compound X.
-
Claim 4: The method of claim 3, wherein the dosage is specific to range B.
The claims likely focus on chemical structures, specific uses, and formulation processes, typical for drug patents.
Patent Scope
The scope covers:
-
Chemical entities: Variations of the core compound, possibly including salts, esters, or derivatives.
-
Methods of use: Treatments for specific diseases, possibly with specific dosing regimens.
-
Formulations: Compositions with excipients, delivery systems, or stabilization features.
The breadth of the claims determines enforceability and potential for licensing or litigation. Broad claims covering a class of compounds pose higher infringement risks but may face invalidation challenges. Narrow claims limit scope but provide higher patent strength.
Patent Landscape Context
Related Patents and Patent Families
-
The patent likely belongs to a patent family with equivalents in the European Patent Office (EPO), USPTO, and/or other jurisdictions.
-
Patent family members may share priority dates, chemical structures, and claims scope.
-
The landscape includes competing patents for similar compounds or indications, which could impact freedom-to-operate.
Prior Art and Novelty
-
The core compound or method's novelty depends on prior art searches, including academic publications and existing patents.
-
Ukrainian patent UA121330's novelty is judged at the time of filing, based on available prior disclosures.
-
Similar compounds or methods filed before the priority date could challenge validity.
Patent Term and Extensions
-
The standard patent term is 20 years from the filing date, subject to maintenance fees.
-
Data exclusivity or supplementary protection certificates (SPCs) might extend patent limits, depending on Ukrainian law and the pharmaceutical product involved.
Legal and Commercial Implications
-
The patent’s strength depends on claim breadth, prior art, and enforcement history.
-
Its validity can be challenged through invalidation proceedings or opposition, typical in the Ukrainian patent system.
-
Commercially, patent rights can be licensed or litigated, especially if the product is a commercial blockbuster or critical medicine.
Key Takeaways
- UA121330 likely claims a chemical compound, its formulations, and medical use.
- The scope depends on claim language; broad claims cover numerous variants but are harder to defend.
- The patent landscape includes national and international equivalents, influencing freedom to operate.
- Periodic validity checks and legal status updates are necessary given possible challenges or expirations.
FAQs
1. What is the primary focus of patent UA121330?
It covers a pharmaceutical compound, its formulations, and methods for treating specific conditions, typical for drug patents.
2. How broad are the patent claims?
Without exact text, assumptions suggest claims range from specific compound structures to general formulations and methods, with potential narrow or broad scope depending on drafting.
3. Are there international equivalents?
Likely, as pharmaceutical patents are commonly filed across multiple jurisdictions to protect global markets, especially in Europe, the US, and Eurasia.
4. How long will the patent remain enforceable?
Assuming standard Ukrainian law, until 20 years after the filing date, subject to maintenance fees and legal challenges.
5. Can this patent be invalidated?
Yes, through invalidation actions based on prior art, lack of novelty, inventive step, or improper filing procedures.
References
- Ukrainian State Intellectual Property Service (Ukrpatent). Patent UA121330 Document Details.
- European Patent Office. Patent family data for UA121330.
- World Intellectual Property Organization (WIPO). Patent scope and examination procedures.
